Temozolomide Capsule
Product Images NDC 70301-2001

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 70301-2001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Temo Structure)

Chemical structure of temozolomide shown as a heterocyclic compound containing nitrogen atoms, a methyl group, and an amide functional group.*

FDA Label Image

Figure (Figure)

A Kaplan-Meier survival curve chart displaying overall survival percentage over time in months for patients with newly diagnosed glioblastoma in a clinical study (MK-7365-051). Two treatment arms are compared: RT + Temozolomide (solid line) and RT Only (dashed line), with survival declining over months and cumulative patients at risk shown below the x-axis.*

FDA Label Image

Label0 (Label0)

Packaging label for Temozolomide 5 mg capsules, USP, for oral administration by OPKO Pharmaceuticals, LLC. The label includes dosage strength (5 mg per capsule), storage instructions (store at 25°C with excursions permitted to 15-30°C), a warning that it is a hazardous drug, and directions to swallow capsules whole without opening. Barcode and revision date 02/2026 are visible.*

FDA Label Image

Label02 (Label02)

Label for Temozolomide Capsule, USP, 5 mg. The front panel shows the product name, strength, dosage form as capsule, and highlights that it is distributed by OPKO Pharmaceuticals, LLC. The warning indicates it is a hazardous drug and advises reading accompanying directions carefully. The back panel includes a barcode and space for lot and expiration information.*

FDA Label Image

Label03 (Label03)

Packaging label for Temozolomide Capsules, USP 5 mg, an oral prescription drug by OPKO Pharmaceuticals, LLC. The label shows the product name, strength (5 mg per capsule), USP designation, and warnings about the drug's hazardous nature. It indicates the package contains 14 individual sachets with one capsule each. Storage instructions and barcode are also visible.*

FDA Label Image

Label04 (Label04)

Label for Temozolomide Capsule, USP 5 mg, an oral human prescription drug by OPKO Pharmaceuticals, LLC. The label includes the drug name, strength (5 mg), distribution information, barcode, lot and expiration placeholders, and a warning indicating it is a hazardous drug with instructions to read accompanying directions carefully.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.